Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

2-Hydroxyestriol

From Wikipedia, the free encyclopedia
2-Hydroxyestriol
Names
IUPAC name
Estra-1,3,5(10)-triene-2,3,16α,17β-tetrol
Systematic IUPAC name
(1R,2R,3aS,3bR,9bS,11aS)-11a-Methyl-2,3,3a,3b,4,5,9b,10,11,11a-decahydro-1H-cyclopenta[a]phenanthrene-1,2,7,8-tetrol
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C18H24O4/c1-18-5-4-10-11(13(18)8-16(21)17(18)22)3-2-9-6-14(19)15(20)7-12(9)10/h6-7,10-11,13,16-17,19-22H,2-5,8H2,1H3/t10-,11+,13-,16+,17-,18-/m0/s1
    Key: ZUGCDOZAVASBQT-SLVREZFOSA-N
  • C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=CC(=C(C=C34)O)O
Properties
C18H24O4
Molar mass304.386 g·mol−1
Hazards
GHS labelling:
H351
P201,P202,P281,P308+P313,P405,P501
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
Chemical compound

2-Hydroxyestriol, also known asestra-1,3,5(10)-triene-2,3,16α,17β-tetrol, is anendogenouscatechol estrogen andmetabolite ofestriol. It is a suspectedcarcinogen of carcinogenicity category 2.[1]

Selected biological properties of endogenous estrogens in rats
EstrogenERTooltip Estrogen receptorRBATooltip relative binding affinity (%)Uterine weight (%)UterotrophyLHTooltip Luteinizing hormone levels (%)SHBGTooltip Sex hormone-binding globulinRBATooltip relative binding affinity (%)
Control100100
Estradiol (E2)100506 ± 20+++12–19100
Estrone (E1)11 ± 8490 ± 22+++?20
Estriol (E3)10 ± 4468 ± 30+++8–183
Estetrol (E4)0.5 ± 0.2?Inactive?1
17α-Estradiol4.2 ± 0.8????
2-Hydroxyestradiol24 ± 7285 ± 8+b31–6128
2-Methoxyestradiol0.05 ± 0.04101Inactive?130
4-Hydroxyestradiol45 ± 12????
4-Methoxyestradiol1.3 ± 0.2260++?9
4-Fluoroestradiola180 ± 43?+++??
2-Hydroxyestrone1.9 ± 0.8130 ± 9Inactive110–1428
2-Methoxyestrone0.01 ± 0.00103 ± 7Inactive95–100120
4-Hydroxyestrone11 ± 4351++21–5035
4-Methoxyestrone0.13 ± 0.04338++65–9212
16α-Hydroxyestrone2.8 ± 1.0552 ± 42+++7–24<0.5
2-Hydroxyestriol0.9 ± 0.3302+b??
2-Methoxyestriol0.01 ± 0.00?Inactive?4
Notes: Values are mean ± SD or range.ERRBA =Relative binding affinity toestrogen receptors of ratuterinecytosol. Uterine weight = Percentage change in uterine wet weight ofovariectomized rats after 72 hours with continuous administration of 1 μg/hour viasubcutaneously implantedosmotic pumps.LH levels =Luteinizing hormone levels relative to baseline of ovariectomized rats after 24 to 72 hours of continuous administration via subcutaneous implant.Footnotes:a =Synthetic (i.e., notendogenous).b = Atypical uterotrophic effect which plateaus within 48 hours (estradiol's uterotrophy continues linearly up to 72 hours).Sources:[2][3][4][5][6][7][8][9][10]

See also

[edit]

References

[edit]
  1. ^"2-HYDROXYESTRIOL". National Center for Biotechnology Information. 17 December 2016.Archived from the original on 26 December 2016. Retrieved26 December 2016.
  2. ^Martucci C, Fishman J (March 1976). "Uterine estrogen receptor binding of catecholestrogens and of estetrol (1,3,5(10)-estratriene-3,15alpha,16alpha,17beta-tetrol)".Steroids.27 (3):325–333.doi:10.1016/0039-128x(76)90054-4.PMID 178074.S2CID 54412821.
  3. ^Martucci C, Fishman J (December 1977). "Direction of estradiol metabolism as a control of its hormonal action--uterotrophic activity of estradiol metabolites".Endocrinology.101 (6):1709–1715.doi:10.1210/endo-101-6-1709.PMID 590186.
  4. ^Fishman J, Martucci C (December 1978)."Differential biological activity of estradiol metabolites".Pediatrics.62 (6 Pt 2):1128–1133.doi:10.1542/peds.62.6.1128.PMID 724350.S2CID 29609115.
  5. ^Martucci CP, Fishman J (December 1979). "Impact of continuously administered catechol estrogens on uterine growth and luteinizing hormone secretion".Endocrinology.105 (6):1288–1292.doi:10.1210/endo-105-6-1288.PMID 499073.
  6. ^Fishman J, Martucci CP (1980). "New Concepts of Estrogenic Activity: the Role of Metabolites in the Expression of Hormone Action". In Pasetto N, Paoletti R, Ambrus JL (eds.).The Menopause and Postmenopause. pp. 43–52.doi:10.1007/978-94-011-7230-1_5.ISBN 978-94-011-7232-5.
  7. ^Fishman J, Martucci C (September 1980). "Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology".The Journal of Clinical Endocrinology and Metabolism.51 (3):611–615.doi:10.1210/jcem-51-3-611.PMID 7190977.
  8. ^Martucci CP (July 1983). "The role of 2-methoxyestrone in estrogen action".Journal of Steroid Biochemistry.19 (1B):635–638.doi:10.1016/0022-4731(83)90229-7.PMID 6310247.
  9. ^Fishman J, Martucci C (1980). "Dissociation of biological activities in metabolites of estradiol". In McLachlan JA (ed.).Estrogens in the Environment: Proceedings of the Symposium on Estrogens in the Environment, Raleigh, North Carolina, U.S.A., September 10-12, 1979. Elsevier. pp. 131–145.ISBN 9780444003720.
  10. ^Kuhl H (August 2005). "Pharmacology of estrogens and progestogens: influence of different routes of administration".Climacteric. 8 Suppl 1:3–63.doi:10.1080/13697130500148875.PMID 16112947.S2CID 24616324.


Precursors
Corticosteroids
Glucocorticoids
Mineralocorticoids
Sex steroids
Androgens
Estrogens
Progestogens
Neurosteroids
Others
ERTooltip Estrogen receptor
Agonists
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
GPERTooltip G protein-coupled estrogen receptor
Agonists
Antagonists
Unknown


This article about anestrane is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=2-Hydroxyestriol&oldid=1308581353"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp